552 related articles for article (PubMed ID: 16173602)
1. Timing of the first endomyocardial biopsy in heart transplantation after induction immunosuppressive therapy--experience from Canadian Heart Transplant Centre.
Málek F; Kaan A; Straatman L; Cheung A; Gnaszewski A
Cas Lek Cesk; 2005; 144(8):507-9; discussion 509. PubMed ID: 16173602
[TBL] [Abstract][Full Text] [Related]
2. Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation.
White JA; Guiraudon C; Pflugfelder PW; Kostuk WJ
J Heart Lung Transplant; 1995; 14(6 Pt 1):1052-6. PubMed ID: 8719450
[TBL] [Abstract][Full Text] [Related]
3. Unsuspected rejection episodes on routine surveillance endomyocardial biopsy post-heart transplant in paediatric patients.
Dixon V; Macauley C; Burch M; Sebire NJ
Pediatr Transplant; 2007 May; 11(3):286-90. PubMed ID: 17430484
[TBL] [Abstract][Full Text] [Related]
4. Utility of surveillance biopsies in infant heart transplant recipients.
Balzer DT; Moorhead S; Saffitz JE; Huddleston CB; Spray TL; Canter CE
J Heart Lung Transplant; 1995; 14(6 Pt 1):1095-101. PubMed ID: 8719456
[TBL] [Abstract][Full Text] [Related]
5. Role of routine endomyocardial biopsy to monitor late rejection after heart transplantation.
Spratt P; Sivathasan C; Macdonald P; Keogh A; Chang V
J Heart Lung Transplant; 1991; 10(6):912-4. PubMed ID: 1756155
[TBL] [Abstract][Full Text] [Related]
6. Routine surveillance endomyocardial biopsy: late rejection after heart transplantation.
Heimansohn DA; Robison RJ; Paris JM; Matheny RG; Bogdon J; Shaar CJ
Ann Thorac Surg; 1997 Nov; 64(5):1231-6. PubMed ID: 9386684
[TBL] [Abstract][Full Text] [Related]
7. Endothelin plasma levels in acute graft rejection after heart transplantation.
Dengler TJ; Zimmermann R; Tiefenbacher CP; Braun K; Sack FU; Kübler W
J Heart Lung Transplant; 1995; 14(6 Pt 1):1057-64. PubMed ID: 8719451
[TBL] [Abstract][Full Text] [Related]
8. The role of right ventricular endomyocardial biopsy in the long-term management of heart-lung transplant recipients.
Glanville AR; Imoto E; Baldwin JC; Billingham ME; Theodore J; Robin ED
J Heart Transplant; 1987; 6(6):357-61. PubMed ID: 3121820
[TBL] [Abstract][Full Text] [Related]
9. How successful is OKT3 rescue therapy for steroid-resistant acute rejection episodes after heart transplantation?
Wagner FM; Reichenspurner H; Uberfuhr P; Kur F; Kaulbach HG; Meiser BM; Ziegler U; Reichart B
J Heart Lung Transplant; 1994; 13(3):438-42; discussion 442-3. PubMed ID: 8061020
[TBL] [Abstract][Full Text] [Related]
10. Acute rejection and endomyocardial biopsy after heart transplantation.
Urbanová D
Cor Vasa; 1990; 32(5):395-400. PubMed ID: 2286087
[TBL] [Abstract][Full Text] [Related]
11. Reliability and usefulness of immunofluorescence in heart transplantation.
Bonnaud EN; Lewis NP; Masek MA; Billingham ME
J Heart Lung Transplant; 1995; 14(1 Pt 1):163-71. PubMed ID: 7727465
[TBL] [Abstract][Full Text] [Related]
12. Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection.
Carlsen J; Johansen M; Boesgaard S; Andersen CB; Arendrup H; Aldershvilet J; Mortensen SA
J Heart Lung Transplant; 2005 Mar; 24(3):296-302. PubMed ID: 15737756
[TBL] [Abstract][Full Text] [Related]
13. Sustained elevated concentrations of cardiac troponin T during acute allograft rejection after heart transplantation in children.
Wåhlander H; Kjellström C; Holmgren D
Transplantation; 2002 Oct; 74(8):1130-5. PubMed ID: 12438959
[TBL] [Abstract][Full Text] [Related]
14. Creatine kinase MB isoforms: a potential predictor of acute cardiac allograft rejection.
Anderson JR; Hossein-Nia M; Brown PA; Corbishley C; Murday AJ; Holt DW
J Heart Lung Transplant; 1995; 14(4):666-70. PubMed ID: 7578173
[TBL] [Abstract][Full Text] [Related]
15. [Hemodynamic study with Swan-Ganz catheterization, concomitant to endomyocardial biopsy in heart transplantation patients. Importance in the early diagnosis of rejection].
Almeida DR; Carvalho AC; Pessoa C; de Sousa JA; Branco JN; Silva LC; Moura L; Castelo HJ; Alves CM; Andrade JC
Arq Bras Cardiol; 1993 Sep; 61(3):171-4. PubMed ID: 8110047
[TBL] [Abstract][Full Text] [Related]
16. Electric myocardial impedance registration in humoral rejection after heart transplantation.
Grauhan O; Müller J; Knosalla C; Cohnert T; Siniawski H; Volk HD; Fietze E; Kupetz W; Hetzer R
J Heart Lung Transplant; 1996 Feb; 15(2):136-43. PubMed ID: 8672516
[TBL] [Abstract][Full Text] [Related]
17. Heart allograft rejection under varying immunosuppressive protocols as evaluated by endomyocardial biopsy.
Imakita M; Tazelaar HD; Billingham ME
J Heart Transplant; 1986; 5(4):279-85. PubMed ID: 3305819
[TBL] [Abstract][Full Text] [Related]
18. Relationship between pharmacokinetic parameters of cyclosporin and the incidence of acute rejection after heart transplantation.
Aumente MD; Arizón JM; Segura J; López A; Albornoz R; Cárdenas M; Segura C
Transplant Proc; 2005 Nov; 37(9):4014-7. PubMed ID: 16386613
[TBL] [Abstract][Full Text] [Related]
19. Early screening for antibody-mediated rejection in heart transplant recipients.
Kfoury AG; Hammond ME; Snow GL; Stehlik J; Reid BB; Long JW; Gilbert EM; Bader FM; Bull DA; Renlund DG
J Heart Lung Transplant; 2007 Dec; 26(12):1264-9. PubMed ID: 18096477
[TBL] [Abstract][Full Text] [Related]
20. Consistencies and controversies in the application of the International Society for Heart and Lung Transplantation working formulation for heart transplant biopsy specimens. Rapamycin Cardiac Rejection Treatment Trial Pathologists.
Winters GL; McManus BM
J Heart Lung Transplant; 1996 Jul; 15(7):728-35. PubMed ID: 8820790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
